ABBV NYSE

AbbVie Inc.

Health Care ·Biopharmaceuticals ·Common Stock
Dividend per share · FY2025$6.65as reported in the 10-K
Latest quarterly dividend$1.73quarter ended 2026-09-30 · filing
Dividend growth · 5 years6.6%compound annual rate
FCF cover · FY20251.53x3-year average 1.74x
Consecutive increases9years, within FY2016–FY2025

ABBV dividend record

Annual figures as reported in AbbVie Inc.’s Form 10-K filings with the US SEC. Free cash flow = operating cash flow − capital expenditure. FCF cover = free cash flow ÷ dividends paid. Each row links to its filing. Data as of SEC EDGAR, retrieved 14 Nov 2026.

Fiscal yearYear endDividend / shareChangeDividends paidFree cash flowFCF coverSource
FY20252025-12$6.65+5.7%$11.66bn$17.82bn1.53x10-K data
FY20242024-12$6.29+5.0%$11.03bn$17.83bn1.62x10-K data
FY20232023-12$5.99+4.9%$10.54bn$22.06bn2.09x10-K data
FY20222022-12$5.71+7.5%$10.04bn$24.25bn2.41x10-K data
FY20212021-12$5.31+9.7%$9.26bn$21.99bn2.37x10-K data
FY20202020-12$4.84+10.3%$7.72bn$16.79bn2.18x10-K data
FY20192019-12$4.39+11.1%$6.37bn$12.77bn2.01x10-K data
FY20182018-12$3.95+50.2%$5.58bn$12.79bn2.29x10-K data
FY20172017-12$2.63+11.9%$4.11bn$9.43bn2.30x10-K data
FY20162016-12$2.35—$3.72bn$6.56bn1.77x10-K data
  • Dividend per share rose every year in the 10-year window shown (FY2016–FY2025). Records before FY2016 are not yet verified on DIVpedia, so we do not state a longer streak.
  • Payout of GAAP net income was above 100% in FY2023–FY2025 because reported earnings include large acquisition-related and other non-cash charges. Free cash flow still covered the dividend 1.5x or more in each of those years.
  • Dividend per share here is the amount declared in each fiscal year. AbbVie declares each year’s first-quarter dividend the previous autumn, so a declared total mixes two dividend rates. The +50% in FY2018 reflects a 35% increase in the quarterly rate early in 2018 plus the higher rate declared that autumn for early 2019.

Original source: AbbVie Inc. filings on SEC EDGAR · How we calculate · Report an error

General information only — not financial advice. Share prices and dividend yields are not shown until a licensed price feed is connected.

About AbbVie Inc.

AbbVie develops and sells medicines in immunology, oncology, neuroscience and aesthetics. It was spun off from Abbott Laboratories in 2013.

Common Stock 1.5-2x Quarterly